Co-Treatment with Cefotaxime and High-Fructose Diet Inducing Nonalcoholic Fatty Liver Disease and Gut Microbial Dysbiosis in Mice

Co-Treatment with Cefotaxime and High-Fructose Diet Inducing Nonalcoholic Fatty Liver Disease and Gut Microbial Dysbiosis in Mice

<b> </b>High fructose diet causes metabolic syndrome and induces host gut microbial dysbiosis and related obesity and nonalcoholic fatty liver disease (NAFLD). Several antibiotic treatments could prevent fatty liver. However, there are studies that have demonstrated that a high-fructose...

Full description

Bibliographic Details
Main Authors: Yen-Peng Lee, Chien-Chao Chiu, Yi-Hsun Chen, Wen-Ching Huang, Yu-Chih Wang, Ching-Feng Chiu, Tien-Jen Lin, Shao-Wen Hung, Ju-Yun Liu, Hsiao-Li Chuang
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Processes
Subjects:
cefotaxime
high-fructose diet
nonalcoholic fatty liver disease
gut microbial
Online Access:https://www.mdpi.com/2227-9717/9/3/434

Internet

https://www.mdpi.com/2227-9717/9/3/434

Similar Items